BIOMAT Database Logo BIOMAT Database Logo

Enzymatically active forms of reverse transcriptase of the human immunodeficiency virus. 1988

F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Instituto di Genetica Biochimica ed Evoluzionistica del CNR, Pavia, Italy.

The reverse transcriptase of HIV-1 (AIDS virus) is characterized by the presence of two highly immunogenic proteins of 66 and 51 kD known to be enzymatically active as a complex p66/51. Using an activity gel procedure that allows identification of catalytic polypeptides in situ after PAGE in denaturing conditions, we visualized two major active bands of 66 and 51 kD of reverse transcriptase from highly purified preparations of HIV-1. We show that both p66 and p51 are enzymatically active. An additional active band was also associated with a 165 kD polypeptide, representing about 2-4% of total activity and possibly corresponding to the putative gag-pol precursor. In H9-infected cells the 66 kD active band became visible 70 hours after infection. These studies show that the two major forms of reverse transcriptase (66 and 51 kD) of HIV-1 are independently active and that a higher Mr form of 165 kD is also enzymatically active.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011061 Poly A A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Adenine Polynucleotides,Polyadenylic Acids,Poly(rA),Polynucleotides, Adenine
D011071 Poly T A group of thymine nucleotides in which the phosphate residues of each thymine nucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Poly dT,Polythymidylic Acids,Thymine Polynucleotides,Polydeoxythymidylate,Acids, Polythymidylic,Polynucleotides, Thymine,dT, Poly
D011119 Polynucleotides BIOPOLYMERS composed of NUCLEOTIDES covalently bonded in a chain. The most common examples are DNA and RNA chains. Polynucleotide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase.
March 1999, FEBS letters,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Many crystal forms of human immunodeficiency virus reverse transcriptase.
January 1991, Journal of molecular biology,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
September 1994, Protein engineering,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Active site studies of human immunodeficiency virus reverse transcriptase.
August 1992, Biochemistry,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.
February 1988, Proceedings of the National Academy of Sciences of the United States of America,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase.
January 1988, DNA (Mary Ann Liebert, Inc.),
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
[Interaction of primers with mutant forms of human immunodeficiency virus reverse transcriptase].
January 1996, Molekuliarnaia biologiia,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Expression of enzymatically active reverse transcriptase of simian immunodeficiency virus in bacteria: sensitivity to nucleotide analogue inhibitors.
December 1990, Virology,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Human Immunodeficiency Virus type 1 reverse transcriptase.
February 1996, Biological chemistry Hoppe-Seyler,
F Lori, and A I Scovassi, and D Zella, and G Achilli, and E Cattaneo, and C Casoli, and U Bertazzoni
Domain structure of the human immunodeficiency virus reverse transcriptase.
March 1992, The EMBO journal,
Copied contents to your clipboard!